Skip to Content

Recent Filings of Interest

Scales of justice, gavel, and law book

GlaxoSmithKline – Advair, Paxil, and Wellbutrin

GlaxoSmithKline LLC allegedly engaged in unfair and deceptive practices when it misrepresented the uses and qualities of its asthma drug, Advair, and antidepressant drugs, Paxil and Wellbutrin. As a result of the investigation and settlement, GSK has agreed to change the way it markets those drugs and refrain from any false, misleading or deceptive promotion of those drugs, which violated the Tennessee Consumer Protection Act. GSK has also agreed to reduce financial incentives for sales representatives to engage in deceptive marketing through at least March 2019. Tennessee worked on the leadership committee of this 45 Attorneys General multistate settlement...GSK filings.

Lethal Injection Challenge

In September 2013, the Tennessee Department of Correction adopted a new single-drug lethal injection protocol governing the execution of prisoners sentenced to death for capital murder convictions. The Attorney General subsequently requested that the Tennessee Supreme Court set execution dates for a number of death-sentenced inmates, who had exhausted the state judicial review processes and whose appeals had been rejected by the federal courts. The inmates now challenge the legality of the protocol in a lawsuit filed in the Davidson County Chancery Court in a case styled Stephen Michael West, et al. v. Derrick D. Schofield, et al..lethal injection challenge filings.

Pfizer/Wyeth – Rapamune

Pfizer Inc, as parent of Wyeth Pharmaceuticals Inc., agrees to be bound by this settlement resolving allegations that Wyeth violated the Tennessee Consumer Protection Act by unlawfully promoting Rapamune, an immunosuppressive drug currently approved by the FDA to help prevent organ rejection after kidney transplant surgery. Allegations included Wyeth making representations related to: (1) the unapproved use of Rapamune following an organ transplant other than a kidney transplant; (2) the unapproved protocol of converting patients to Rapamune after initially receiving a different immunosuppressive drug; and (3) using Rapamune in unapproved drug combinations. The settlement requires Pfizer to ensure that its marketing and promotional practices do not unlawfully promote Rapamune or any other Pfizer drug. Tennessee and 41 other attorneys general participated in this consumer protection settlement....Rapamune filings.


On June 17, 2014, Tennessee, along with the Attorneys General of 48 states and the District of Columbia, the U.S. Department of Justice (DOJ), the U.S. Department of Housing and Urban Development (HUD),and the Consumer Financial Protection Bureau (CFPB), reached a $550 million joint-state federal settlement with mortgage lender and servicer SunTrust Mortgage Inc. to address origination, servicing, and foreclosure abuse. This agreement provides servicing standards to improve homeowner communications with SunTrust, and also relief to eligible homeowners through principal reduction and cash payments to foreclosed borrowers....SunTrust filings.